Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Genocea Biosciences stock in Canada
Own Genocea Biosciences shares in just a few minutes.
Genocea Biosciences is a biotechnology business based in the US. Genocea Biosciences stocks (GNCA.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.33 – the same closing value as a week prior. Genocea Biosciences employs 72 staff and has a trailing 12-month revenue of around $1.6 million.
How to buy shares in Genocea Biosciences
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – GNCA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Is it a good time to buy Genocea Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
What's in this guide?
- Can I buy shares in Genocea Biosciences?
- Has coronavirus impacted Genocea Biosciences shares?
- Genocea Biosciences shares summary
- Compare share dealing platforms
- Is Genocea Biosciences stock a buy or sell?
- Genocea Biosciences performance over time
- Genocea Biosciences's financials
- How volatile are Genocea Biosciences shares?
- Does Genocea Biosciences pay a dividend?
- Have Genocea Biosciences shares ever split?
- Other common questions
How has Coronavirus impacted Genocea Biosciences's stock price?
Since the stock market crash in March caused by coronavirus, Genocea Biosciences's stock price has had significant negative movement.
Its last market close was $1.03, which is 51.87% down on its pre-crash value of $2.14 and 6.80% down on the lowest point reached during the March crash when the stocks fell as low as $1.1.
If you had bought $1,000 worth of Genocea Biosciences stocks at the start of February 2020, those stocks would have been worth $699.03 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $500.00.
Genocea Biosciences stock price (NASDAQ:GNCA)Use our graph to track the performance of GNCA stocks over time.
Genocea Biosciences shares at a glance
|Latest market close||$1.03|
|52-week range||$0.91 - $4.05|
|50-day moving average||$1.35|
|200-day moving average||$1.95|
|Wall St. target price||$6.13|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.75|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Genocea Biosciences price performance over time
|1 week (2022-01-06)||-2.83%|
|1 month (2021-12-15)||6.13%|
|3 months (2021-10-15)||-41.48%|
|6 months (2021-07-16)||-51.30%|
|1 year (2021-01-15)||-61.99%|
|2 years (2020-01-16)||-62.27%|
|3 years (2019-01-16)||69.69%|
|5 years (2017-01-13)||4.39|
Genocea Biosciences financials
|Revenue TTM||$1.6 million|
|Gross profit TTM||$1.4 million|
|Return on assets TTM||-36.82%|
|Return on equity TTM||-120.28%|
|Market capitalisation||$59.2 million|
TTM: trailing 12 months
Genocea Biosciences share dividends
We're not expecting Genocea Biosciences to pay a dividend over the next 12 months.
Have Genocea Biosciences's shares ever split?
Genocea Biosciences's shares were split on a 1:8 basis on 21 May 2019. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Genocea Biosciences shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for Genocea Biosciences shares which in turn could have impacted Genocea Biosciences's share price.
Genocea Biosciences share price volatility
Over the last 12 months, Genocea Biosciences's shares have ranged in value from as little as $0.91 up to $4.045. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Genocea Biosciences's is 1.3938. This would suggest that Genocea Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Genocea Biosciences overview
Genocea Biosciences, Inc. , a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy using neoantigen-targeted peripheral cells for ATLAS identified anti-tumor antigens that are used to manufacture peripheral blood-derived tumor-specific T cell therapy; and GEN-009, a neoantigen vaccine candidate, delivering adjuvanted synthetic long peptides spanning ATLAS-identified anti-tumor neoantigens. The company was incorporated in 2006 and is based in Cambridge, Massachusetts. .
Stocks similar to Genocea Biosciences
Frequently asked questions
Genocea Biosciences in the news
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
Joe Manchin's former aides gain influential lobbying clients as their ex-boss battles Biden's agenda
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.
GreenTrust (GNT) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy GreenTrust, lists some exchanges where you can get it and provides daily price data on GNT.
Ask an Expert
You must be logged in to post a comment.